1. Immunomodulatory Efficacy-mediated anti-HBV and anti-HBV Potential of Kefir Grains; Unveiling the in Vitro Antibacterial, Antifungal, and Wound Healing Activities. Ellatif, S.A., E.S. Abdel Razik, M.M. Abu-Serie, A. Mahfouz, A.F. Shater, F.M. Saleh, M.M. Hassan, W.F. Alsanie, A. Altalhi, G.E. Daigham, and A.Y. Mahfouz. Molecules, 2022. 27(6): 2016. PMID[35335377]. PMCID[PMC8951848].
[PubMed]. HBV_03_2022.
2. Discovery of SHR5133, a Highly Potent and Novel HBV Capsid Assembly Modulator. Li, X., Z. Zhang, Y. Chen, B. Wang, G. Yang, X. Xu, B. Yechao, D. Bai, B. Feng, Y. Mao, J. Feng, C. Bai, F. He, and W. Tao. American Chemical Society Medicinal Chemistry Letters, 2022. 13(3): p. 507-512. PMID[35300087]. PMID[PMC8919393].
[PubMed]. HBV_03_2022.
3. Isolation and Characterization of Two Chalcone Derivatives with anti-Hepatitis B Virus Activity from the Endemic Socotraen Dracaena cinnabari (Dragon's Blood Tree). Mothana, R.A., A.H. Arbab, A.A. ElGamal, M.K. Parvez, and M.S. Al-Dosari. Molecules, 2022. 27(3): 952. PMID[35164217]. PMCID[PMC8838591].
[PubMed]. HBV_03_2022.
4. Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives. Nishiuchi, K., H. Ohashi, K. Nishioka, M. Yamasaki, M. Furuta, T. Mashiko, S. Tomoshige, K. Ohgane, S. Kamisuki, K. Watashi, and K. Kuramochi. Journal of Natural Products, 2022. 85(1): p. 284-291. PMID[34967639]. PMCID[PMC8751641].
[PubMed]. HBV_03_2022.
5. Design and Synthesis of Novel Quinazolinone Derivatives as anti-HBV Agents with TLR8 Agonist Effect. Qiu, J., Q. Zhou, Y. Zou, S. Li, L. Yang, W. Chen, J. Gao, and X. Gu. European Journal of Medicinal Chemistry, 2022. 231: 114159. PMID[35123297].
[PubMed]. HBV_03_2022.
6. S2DV: Converting Smiles to a Drug Vector for Predicting the Activity of anti-HBV Small Molecules. Shao, J., Q. Gong, Z. Yin, W. Pan, S. Pandiyan, and L. Wang. Briefings in Bioinformatics, 2022. 23(2): bbab593. PMID[35062019].
[PubMed]. HBV_03_2022.
7. Structure-based Molecular Networking for the Discovery of anti-HBV Compounds from Saussurea lappa (Decne.) C.B Clarke. Wu, T., X.J. Yan, T.R. Yang, Y.F. Wang, J.Y. He, Y. Feng, L.H. Su, H. Chen, and M. Xu. Molecules, 2022. 27(6): 2023. PMID[35335386]. PMCID[PMC8955460].
[PubMed]. HBV_03_2022.
8. A Polysaccharide from Eupolyphaga sinensis Walker with anti-HBV Activities in Vitro and in Vivo. Zhang, X., H. Su, H. Yu, J. Ding, W. Deng, B. Qin, C. Zhou, J. Dou, and M. Guo. Frontiers in Pharmacology, 2022. 13: 827128. PMID[35308231].
[PubMed]. HBV_03_2022.
9. Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety. Zhang, X.W., M.C. Li, and J.J. Dou. Bulletin of Experimental Biology and Medicine, 2022. 172(5): p. 573-578. PMID[35352245].
[PubMed]. HBV_03_2022.
10. The Underlying Mechanisms of anti-Hepatitis B Effects of Formula Le-Cao-Shi and Its Single Herbs by Network Pharmacology and Gut Microbiota Analysis. Zhao, Q., S.Y. Song, Y.Q. Zhang, X. Ren, P. Zhang, X. Li, X.M. Fu, and C.Y. Wang. Biomedicine & Pharmacotherapy, 2022. 148 112692:. PMID[35151160].
[PubMed]. HBV_03_2022.
Patent Citations
11. Preparation of Fused Ring Pyrimidone Derivatives for the Treatment of HBV Infection or of HDV-Induced Diseases. Liu, L., G. Deng, C. Lu, Z. Liu, S.C. Grosse, K. Vandyck, E. Jacoby, T.H.M. Jonckers, P.J.-M.B. Raboisson, S.J. Last, S.M.A. Pieters, M. Perrier, W.G. Verschueren, and C. Martinez Lamenca. Patent. 2022. 2021-CN117601 2022053010: 354pp.
[Patent]. HBV_03_2022.